Federal Agricultural Mortgage Corp
AGM NYSE Federal & Federally-Sponsored Credit Agencies Financials FY2016βFY2025
What Federal Agricultural Mortgage Corp does
No business description yet.
- Legal name
- FEDERAL AGRICULTURAL MORTGAGE CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 19, 2026
- Accession Β· CIK
- 0000845877-26-000014
0000845877
Revenue and margins
Federal Agricultural Mortgage Corp had $408M of revenue in fiscal 2025, up 8.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 12.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $80.1M in fiscal 2025, 19.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Federal Agricultural Mortgage Corp returned $12.9M to shareholders in fiscal 2025, 16% of free cash flow. The diluted share count rose 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Federal Agricultural Mortgage Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $909M | $861M | $889M | $1.0B | $931M |
| Debt incl. finance leases | $22.8B | $25.0B | $26.6B | $27.5B | $30.8B |
| Debt / equity | 18.8x | 19.7x | 18.8x | 18.5x | 17.9x |
| Total assets | $25.1B | $27.3B | $29.5B | $31.3B | $35.4B |
| Total liabilities | $23.9B | $26.1B | $28.1B | $29.8B | $33.7B |
| Shareholders' equity | $1.2B | $1.3B | $1.4B | $1.5B | $1.7B |
| Net debt (β = net cash) | $21.8B | $24.1B | $25.7B | $26.5B | $29.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 6 / 7 | 1 / 7 | 2 / 7 | 5 / 7 | 5 / 7 | 6 / 7 | 5 / 7 | 3 / 7 |
| Accruals ratio | β0.9% | β0.5% | β0.5% | 0.6% | 0.9% | β1.2% | β2.4% | β0.6% | β1.3% | 0.4% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $161M | $175M | $186M | $194M | $214M | $245M | $310M | $351M | $375M | $408M |
| Net interest income | $140M | $158M | $174M | $173M | $196M | $222M | $271M | $328M | $354M | $391M |
| Noninterest income | $20.5M | $17.5M | $11.6M | $20.9M | $18.0M | $23.1M | $38.7M | $23.5M | $21.2M | $17.6M |
| Noninterest expense | $40.3M | $42.8M | $49.9M | $51.9M | $61.7M | $72.1M | $82.1M | $97.4M | β | β |
| Provision for credit losses | $1.0M | $1.8M | $0.3M | $3.5M | $8.1M | β$2.2M | $0.8M | $1.1M | $11.5M | $32.9M |
| Interest expense | $172M | $243M | $370M | $472M | $313M | $204M | $446M | $1.1B | β | β |
| Pretax income | $119M | $131M | $136M | $139M | $145M | $172M | $226M | $253M | $258M | $256M |
| Income tax | $42.1M | $46.4M | $27.9M | $29.1M | $30.3M | $36.4M | $47.5M | $53.1M | $50.9M | $48.3M |
| Net income | $77.3M | $84.5M | $108M | $110M | $114M | $136M | $178M | $200M | $207M | $207M |
| Net income to common | $64.2M | $71.3M | $94.9M | $93.7M | $94.9M | $111M | $151M | $173M | $180M | $182M |
| Diluted EPS | $5.97 | $6.60 | $8.83 | $8.69 | $8.80 | $10.27 | $13.87 | $15.81 | $16.44 | $16.62 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $213M | $175M | $200M | β$19.7M | β$94.5M | $436M | $809M | $376M | $613M | $80.1M |
| Capital expenditure | β | β | β | β | β | β | $0.0M | $0.0M | $5.3M | $0.0M |
| Free cash flow | β | β | β | β | β | β | $809M | $376M | $607M | $80.1M |
| Stock-based compensation | $3.3M | $2.7M | $2.5M | $2.3M | $4.1M | $4.3M | $4.6M | $6.8M | $8.1M | $8.3M |
| Share buybacks | β | β | $0.0M | $0.0M | $0.2M | $0.0M | $0.0M | $0.0M | $0.0M | $12.9M |
| Dividends and buybacks | β | β | $0.0M | $0.0M | $0.2M | $0.0M | $0.0M | $0.0M | $0.0M | $12.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $265M | $302M | $425M | $604M | $1.0B | $909M | $861M | $889M | $1.0B | $931M |
| Total debt | $13.7B | $15.5B | $24.0B | $29.1B | $21.8B | $22.8B | $25.0B | $26.6B | $27.5B | $30.8B |
| Loans, net | $4.5B | $5.3B | $5.5B | $7.0B | $8.5B | $9.2B | $10.2B | $11.0B | $13.2B | $16.3B |
| Total assets | $15.6B | $17.8B | $18.7B | $21.7B | $24.3B | $25.1B | $27.3B | $29.5B | $31.3B | $35.4B |
| Total liabilities | $15.0B | $17.1B | $17.9B | $20.9B | $23.4B | $23.9B | $26.1B | $28.1B | $29.8B | $33.7B |
| Shareholders' equity | $643M | $708M | $753M | $799M | $998M | $1.2B | $1.3B | $1.4B | $1.5B | $1.7B |
| Margins | ||||||||||
| Net margin | 48.1% | 48.2% | 58.1% | 56.4% | 53.5% | 55.5% | 57.5% | 57.0% | 55.2% | 50.8% |
| FCF margin | β | β | β | β | β | β | 261.4% | 107.0% | 161.9% | 19.6% |
| Net interest share of revenue | 87.3% | 90.0% | 93.7% | 89.2% | 91.6% | 90.6% | 87.5% | 93.3% | 94.3% | 95.7% |
| Efficiency ratio | 25.1% | 24.4% | 26.8% | 26.8% | 28.8% | 29.4% | 26.5% | 27.7% | β | β |
| Returns | ||||||||||
| Return on equity | 12.0% | 12.5% | 14.8% | 14.1% | 12.7% | 12.3% | 14.3% | 14.9% | 14.3% | 12.9% |
| Return on assets | 0.5% | 0.5% | 0.6% | 0.5% | 0.5% | 0.6% | 0.7% | 0.7% | 0.7% | 0.6% |
| Return on tangible equity | 10.0% | 10.1% | 12.6% | 11.7% | 9.5% | 9.2% | 11.9% | 12.2% | 12.1% | 10.6% |
| Growth | ||||||||||
| Revenue growth | β | 9.0% | 6.2% | 4.3% | 10.2% | 14.6% | 26.4% | 13.4% | 6.8% | 8.9% |
| Net income growth | β | 9.2% | 27.9% | 1.4% | 4.4% | 19.0% | 30.9% | 12.3% | 3.6% | 0.1% |
| EPS growth | β | 10.6% | 33.8% | β1.6% | 1.3% | 16.7% | 35.1% | 14.0% | 4.0% | 1.1% |
| FCF growth | β | β | β | β | β | β | β | β53.6% | 61.6% | β86.8% |
| Share count change | β | 0.5% | β0.5% | 0.3% | 0.1% | 0.6% | 0.3% | 0.5% | 0.3% | 0.1% |
| Financial health | ||||||||||
| Debt / equity | 21.2x | 21.9x | 31.9x | 36.4x | 21.8x | 18.8x | 19.7x | 18.8x | 18.5x | 17.9x |
| Provision / loans | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | β0.0% | 0.0% | 0.0% | 0.1% | 0.2% |
| Capital allocation | ||||||||||
| Capex / revenue | β | β | β | β | β | β | 0.0% | 0.0% | 1.4% | 0.0% |
| Stock comp / revenue | 2.1% | 1.5% | 1.4% | 1.2% | 1.9% | 1.8% | 1.5% | 1.9% | 2.2% | 2.0% |
| Payouts / FCF | β | β | β | β | β | β | 0.0% | 0.0% | 0.0% | 16.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 1.0 | 2.0 | 5.0 | 5.0 | 6.0 | 5.0 | 3.0 |
| Accruals ratio | β0.9% | β0.5% | β0.5% | 0.6% | 0.9% | β1.2% | β2.4% | β0.6% | β1.3% | 0.4% |
Source: SEC EDGAR XBRL filings (CIK 0000845877). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.